Return to Pharmacology
Download a copy of this study guide
| Drug Name | Category | Comments |
| Acebutolol | CV; Anti-HTN
beta1-Blocker (cardioselective) Anti-Arrhythmic; Class II |
Given PO; Has partial beta-agonist activity. Cardioselective: safer for use with asthmatics. |
| Acetazolamide | Diuretic
Carbonic-Anhydrase Inhibitor CNS; Anti-Convulsive; Petit-mal |
Causes mild alkaline diuresis and metabolic acidosis.
Diuretic: Used to increase urinary excretion of weak acids: counteract salicylate and phenobarbitol poisoning. Anti-Convulsive: In CNS, indicated for treatment of petit-mal seizures, as it increases CO2 in brain which increases seizure threshold. Tolerance develops to its use. Also can be used to stimulate respiration in acute mountain sickness. |
| Acetophenazine | CNS; Anti-Psychotic
Phenothiazine; piperazine |
More extra-pyramidal and anti-emetic effects. |
| Adenosine | CV; Anti-Arrhythmic | Indicated for Paroxysmal Supraventricular Tachycardia |
| Al(OH)3 | GI; Peptic Ulcer
Antacid |
Local antacid; not absorbed. Weakest antacid. Has constipation as side-effect. Give it with Magnesium
(as in Mylanta) to minimize side-effect.
It depletes phosphate. Indicated for hyperphosphatemia: Al+3 binds with excess PO4-3 in bowel and is excreted in feces. |
| Albuterol | Anti-Asthma
Bronchodilator; beta2-agonist |
Given inhaled or PO. Not a substrate for COMT, thus longer duration. |
| Alprazolam
(Xanax) |
CNS; Depressant
Benzodiazepine |
|
| Alprenolol | CV; Anti-HTN
beta-Blocker (non-selective) |
Has partial beta-agonist activity. |
| Alprostadil
(PGE1) |
Autocoid; PG Analog | Used to maintain patent ductus arteriosus, in certain heart defects such as Tetralogy of Fallot. |
| Amantadine | CNS; Movement Disorders
Anti-Parkinsonism Anti-Viral Agent |
Anti-viral agent has some efficacy with Parkinson's. Used as adjunct therapy. |
| Amiloride | Diuretic
K+-sparing Diuretic |
It inhibits Na+/K+-ATPase in collecting ducts. |
| Aminophylline | Anti-Asthma
Bronchodilator; methylxanthine |
Theophylline conjugate, given IV.
Phosphodiesterase Inhibitor ------> high cAMP ------> adrenergic and anti-inflammatory effects in lungs. It is usually given IV for acute attacks, and it has a narrow therapeutic range, so it must be monitored carefully. |
| Amiodarone | CV; Anti-Arrhythmic
All classes |
Used to treat life-threatening arrhythmias when other agents have failed.
Given PO. Actions: (1) Prolong action potential duration, (2) prolong refractory period, (3) alpha-adrenoceptor blockade, and (4) beta-adrenoceptor blockade. Indications: Suppresses PVC's, ventricular tachycardias Adverse Effects: Pulmonary, hepatic toxicity; increases serum concentrations of other cardiac drugs. |
| Amirone | CV; Anti-CHF
Bipyrine |
Phosphodiesterase inhibitor ------> higher cAMP and Ca+2 ------> increase inotropic state. |
| Amitriptyline
(Elavil) |
CNS; Anti-Depressant
1st Generation Tri-Cyclic |
Profound Sedation: Useful in patients who may benefit from sedation, but not for treatment of insomnia per se. Cardiotoxic. |
| Amlodipine | CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker; Dihydropyridine |
|
| Amoxapine | CNS; Anti-Depressant
2nd Generation Miscellaneous |
May have some anti-psychotic effects. Resembles loxapine, clozapine. |
| Amyl Nitrite | CV; Anti-Anginal
Nitrates & Nitrites |
Volatile liquid, given by inhalation. It is the fastest acting of preparations.
Can cause methemoglobinemia in high doses. |
| Astemizole | Anti-Histamine (H1)
Non-sedating |
Less sedating; does not cross BBB.
Blood levels go up with Erythromycin and Ketoconazole (due to Cyt-P450) ------> fatal arrhythmias. |
| Atenolol | CV; Anti-HTN
beta1-Blocker (cardioselective) |
|
| Atracurium | Muscle-Relaxant; Competitive | |
| Attapulgite | GI; Anti-emetic; adsorbent | |
| Azatadine | Anti-Histamine (H1) | |
| Baclofen | CNS; Movement Disorders
Anti-Spasmodic |
GABAB Agonist, a subset of GABA receptors. Inhibits spinal reflexes, raises depolarization threshold. Most affects gamma motor system. Used in spinal-cord injuries and multiple sclerosis. |
| Beclomethasone | Anti-Asthma
Anti-Inflammatory; Corticosteroid |
The preferred steroid for Asthma treatment. It is effective in the lungs, and is not absorbed readily
when inhaled.
Long-term, Cortisol reduces inflammation. Short-term, it can help to increase beta2 receptor-density in asthmatics who have beta2 down-regulation due to excessive use of bronchodilators. |
| Benazepril | CV; Anti-HTN, Anti-CHF
ACE-Inhibitor; pro-drug |
|
| Benzocaine | Local Anesthetic; Ester | Effective as topical agent; it penetrates mucous membranes |
| Benzoflumethiazide | Diuretic; Anti-HTN
Thiazide Diuretic |
Lipid soluble, more potent and longer acting. Extensively metabolized. |
| Benztropine | CNS; Movement Disorders
Anti-Parkinsonism Anti-Cholinergic |
Centrally acting anti-cholinergic used as adjunct therapy in Parkinson's, to inhibit cholinergic interneurons. Can be used as adjunct therapy with anti-psychotics, to attenuate extra-pyramidal effects. |
| Bepridil | CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker |
Given parenterally. |
| Betamethasone | Anti-Asthma
Anti-Inflammatory; Corticosteroid |
Inhalant. Well-absorbed with many systemic effects. |
| Betaxolol | CV; Anti-HTN
beta1-Blocker (cardioselective) |
|
| Bisacodyl | GI; Laxative
Contact-stimulant |
Synthetic agent. Treat constipation. Evacuate colon before surgery.
Frequently gives as suppository; may cause GI irritation if given PO. |
| Bismuth Subsalicylate
(Pepto-Bismol) |
GI; Peptic Ulcer
Cytoprotective Agent Anti-emetic |
Selectively binds to ulcer, providing coating and protection. Stimulate mucus production and PGE1 synthesis. Has anti-microbial activity; often used in combination therapy with antibiotics, to fight H. Pylori |
| Bitolterol | Anti-Asthma
Bronchodilator; beta2-agonist |
|
| Bretylium | CV; Anti-Arrhythmic
Class-III (K+-Blocker) |
Also has anti-adrenergic properties (similar to reserpine). Toxicity ------> hypotension. |
| Bromocriptine | CNS; Movement Disorders
Anti-Parkinsonism Ergoline Dopamine D2 Agonist |
Adjunct therapy to L-DOPA treatment, in patients who don't respond well to L-DOPA by itself. First-pass metabolism; adverse effects similar to L-DOPA. |
| Budesonide | Anti-Asthma
Anti-Inflammatory; Corticosteroid |
|
| Bumetanide | Diuretic; Anti-CHF
Loop Diuretic; sulfonamide |
Fast, reversible diuresis. Also inhibits Na3PO4 cotransporter. |
| Bupivacaine | Local Anesthetic; Amide | Used for infiltration anesthesia, peripheral nerve block, epidural block. |
| Bupropion | CNS; Anti-Depressant
2nd Generation Miscellaneous |
Fewer anti-cholinergic side-effects than TCA's. Not used much. |
| Buspirone | CNS
Anxiolytic |
Partial agonist at Serotonin 5-HT1 receptors. It is not a sedative and is not habit-forming. If you take too much, you actually feel worse instead of better. Must be taken for weeks before it takes effect. |
| CaCO3 | GI; Peptic Ulcer
Antacid |
Local antacid; not absorbed. Most neutralizing.
Adverse effects: (1) constipation. (2) Can lead to acid-rebound when therapy is stopped, as Ca+2 can stimulate gastric secretion. (3) Hypercalcemia and hyperphosphatemia can lead to renal stones with chronic use. (4) Milk-alkali syndrome. |
| Calcium polycarbophil | GI; Laxative
Bulk-forming agent |
|
| Captopril | CV; Anti-HTN, Anti-CHF
ACE-Inhibitor; active drug |
Orally active drug. |
| Carbamazepine
(Tegretol) |
CNS; Anti-Convulsive
Grand-mal Iminostilbene |
Grand-mal / partial treatment. Can also be used to treat (1) Bipolar Disorder, and (2) Trigeminal and
Glossopharyngeal neuralgias.
MECH = prolong inactivation of Na+ channels, increasing seizure threshold. Often less sedating than Phenytoin. Slow and erratic oral absorption. Side Effects = sedation, ataxia, diplopia, nausea, vomiting. |
| Carbenoxolone | GI; Peptic Ulcer
Cytoprotective Agent |
Lots of side effects; rarely used |
| Carbidopa | CNS; Movement Disorders
Anti-Parkinsonism |
Inhibits Aromatic Amino-acid Decarboxylase (AADC) in the periphery, preventing peripheral effects of L-DOPA. |
| Carboprost | Autocoid; PG Analog | Longer-acting PG analog. Induces abortion. |
| Carteolol | CV; Anti-HTN
beta-Blocker (non-selective) |
Has partial beta-agonist activity. |
| Cascara Sagrada
(Castor oil) |
GI; Laxative
Contact-stimulant |
From cascara plant. They stimulate GI mucosa ------> increase motility and secretions.
It is not active unless hydrolyzed. |
| Chenodiol | GI; Gallstones | Natural bile salt reduces cholesterol secretion and increases bile salts, thereby solubilizing the bile. Administered for 9-12 months. |
| Chloral Hydrate | CNS; Depressant | Hypnotic; rapid onset and short duration of action. Trichloroethanol is the active metabolite. Irritates GI tract. Sometimes used with children. |
| Chlorcyclizine | Anti-Histamine (H1) | Less sedating. Best for daytime use. |
| Chlorcyclizine | Anti-Histamine (H1)
Piperazine |
A piperazine. Used in treatment of motion sickness. |
| Chlordiazepoxide
(Librium) |
CNS; Depressant
Benzodiazepine |
Has a long effective half-life, due to the presence of active metabolites. |
| Chloroprocaine | Local Anesthetic; Ester | |
| Chlorothiazide | Diuretic; Anti-HTN
Thiazide Diuretic |
|
| Chlorpheniramine | Anti-Histamine (H1) | Less sedating and fewer GI effects. Best for daytime use. |
| Chlorpromazine
(Thorazine) |
CNS; Anti-Psychotic
Phenothiazine; aliphatic |
High sedative effects, which can be anxiolytic. Prototype and least potent of neuroleptics. Can also be used to treat endogenous depression with psychotic features. |
| Chlorprothixene | CNS; Anti-Psychotic
Thioxanthenes |
Low hypotensive effects. |
| Chlorthalidone | Diuretic; Anti-HTN
Thiazide Diuretic |
Used to treat HTN. |
| Cholestyramine | CV; Anti-Lipidemic
Bile-acid binding resin GI; Anti-emetic; adsorbent |
Lower plasma LDL. Increases excretion of bile salts ------> decreased serum cholesterol and increased
LDL receptors.
Indications: wherever LDL is elevated: Hypocholesterolemia (IIa), Combined Hyperlipoproteinemia (IIb). |
| Cimetidine
(Tagamet) |
GI; Peptic Ulcer
H2-Blocker |
First and least potent drug. Gets into breast milk. T1/2 = 2 hrs. Known to be effective with duodenal ulcers,
less effective with gastric ulcers.
Adverse Effects: (1) Inhibits Phase-I oxidation (Cyt-P450) ------> increased levels of warfarin, diazepam, phenytoin, theophylline. (2) Gynecomastia and Impotence, (3) mental confusion, (4) diarrhea |
| Clofibrate | CV; Anti-Lipidemic
Fibric-acid derivative |
Lower plasma VLDL. Increase lipoprotein lipase activity ------> promote catabolism of VLDL.
Indications: wherever VLDL is elevated: Dysbetalipoproteinemia (III), Hypertriglyceridemia (IV), Chylomicronemia (V) |
| Clomipramine | CNS; Anti-Depressant
1st Generation Tri-Cyclic |
Beneficial in treating OCD. Extra Cl- probably confers (1) specificity for OCD, and (2) specificity for
serotonin receptors, making this drug similar to an SSRI.
Strongly anti-cholinergic and sedating. |
| Clonazepam | CNS; Depressant
Benzodiazepine |
Used in the treatment of Petit-mal seizures. Tolerance develops, so long-term therapy is contraindicated. |
| Clonidine | CV; Anti-HTN; Sympatholytic
alpha2-agonist |
Direct alpha2-agonist ------> decrease sympathetic tone.
Withdraw drug gradually: sudden withdrawal may cause hypertensive crisis. |
| Clorazepate | CNS; Depressant
Benzodiazepine |
Used as adjunct therapy in complex partial seizures. |
| Clorgyline | CNS; Anti-Depressant
1st Generation MAO-Inhibitor |
|
| Clozapine | CNS; Anti-Psychotic
Miscellaneous |
Has a higher affinity for 5-HT2 serotonin receptors than for D2 receptors.
Has no extra-pyramidal effects, and also is the only drug to help at all with the negative symptoms of Schizophrenia. Often works when the other neuroleptics fail; similar in structure to tri-cyclics. Still only used as second-line drug, because it has a high incidence (3%) of agranulocytosis. Blood-monitoring is mandatory when taking the drug. |
| Cocaine | Local Anesthetic; Ester | Effective as topical agent; it penetrates mucous membranes |
| Codeine | CNS; Opioid Analgesic
Anti-Tussive |
Readily crosses BBB. Used to treat mild pain. |
| Colestipol | CV; Anti-Lipidemic
Bile-acid binding resin |
Lower plasma LDL. Increases excretion of bile salts ------> decreased serum cholesterol and increased
LDL receptors.
Indications: wherever LDL is elevated: Hypocholesterolemia (IIa), Combined Hyperlipoproteinemia (IIb). |
| Colloidal Bismuth
Subcitrate
(De Nol) |
GI; Peptic Ulcer
Cytoprotective Agent |
Cytoprotective, plus antimicrobial activity against H. Pylori |
| Cromolyn-Sodium | Anti-Asthma
Anti-Inflammatory Block Histamine Degranulation |
Inhibits degranulation of Mast-Cell granules. They are thought to inhibit calcium flux in Mast cells
------> inhibit release of histamine, leukotrienes, and other mediators.
Often used for prophylaxis, between asthma attacks. |
| Cyclizine | Anti-Histamine (H1) | Used in treatment of motion sickness. |
| Cyproheptadine | Anti-Histamine (H1)
5-HT1 Antagonist |
Used in treatment of urticaria. |
| Cytellin | CV; Anti-Lipidemic | Interferes with intestinal absorption of cholesterol. Indicated for Familial Hypercholesterolemia (IIa) or exogenous hypercholesterolemia. Modest effect with minimal side-effects. |
| Dantrolene | CNS; Movement Disorders
Anti-Spasmodic |
It decreases Ca+2 release from the muscle SR. Adverse Effects = generalized muscle weakness, hepatotoxicity. Indications: (1) Wide variety of spastic disorders, (2) malignant hyperthermia. |
| Decamethonium | Muscle-Relaxant; Depolarizing | |
| Demeclocycline | ADH Antagonist
Tetracycline |
Inhibit the action of ADH at some point distal to formation of cAMP. Lithium has the same property, as a
side-effect of treatment.
Adverse Effects: Abnormalities of bone and teeth in young children. |
| Demeclocycline | Diuretic
ADH Antagonist |
Indicated for hyper-ADH conditions, such as an ADH-secreting tumor. |
| Desipramine | CNS; Anti-Depressant
1st Generation Tri-Cyclic |
The active metabolite of imipramine; more potent than imipramine. May be used in management of
chronic pain.
Preferred TCA for geriatric population, because of minimal sedation and anti-cholinergic effects. |
| Desmopressin (DDAVP) | ADH Analog | Indicated for Diabetes Insipidus. More stable, more frequently used ADH analog.
Administered intranasally or SQ. |
| Dexamethasone | Anti-Asthma
Anti-Inflammatory; Corticosteroid |
Inhalant. Well-absorbed with many systemic effects. |
| Dextromethorphan | Anti-Tussive | Most popular drug, primarily used to suppress cough. |
| Dextrothyroxine | CV; Anti-Lipidemic | Enhances removal of LDL. Toxicity = hypermetabolism. Contraindicated in CAD, HTN. |
| Dezocine | CNS; Opioid Analgesic | |
| Diazepam
(Valium) |
CNS; Depressant
Benzodiazepine |
Has very long half-life, due to inherently long T1/2 plus active metabolites. Anxiolytic at low doses, sedative
at higher doses.
Used as (1) Anxiolytic (low dose), (2) Anti-convulsant (Status Epilepticus), (3) Pre-anesthetic medication, (4) Anti-Spasmodic Half-life prolonged by cimetidine. |
| Diazoxide | CV; Anti-HTN
Vasodilator |
Given IV, for hypertensive emergencies. Relaxes only arteriolar smooth muscle. |
| Digitoxin | CV; Anti-CHF
Cardiac Glycoside |
Only available PO. Longer-acting, and longer duration. 3-4 weeks to reach steady state. |
| Digoxin | CV; Anti-CHF
Cardiac Glycoside Anti-Arrhythmic |
Available IV, IM, or PO.
Anti-CHF: More popular of the two, because (1) faster acting and shorter duration, (2) Can be given IM or PO, and (3) blood levels can be monitored. 1 week to reach steady state. Anti-Arrhythmic: It should be administered before quinidine in the treatment of atrial fibrillation -- it does not stop fibrillation, but by inducing heart-block it prevents it from progressing to ventricular fibrillation. |
| Dihydrocodeine | Anti-Tussive | |
| Diltiazem
(Cardizem) |
CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker Anti-Arrhythmic; Class-IV |
Benzothiazepine compound.
Anti-Arrhythmic: Treatment of Paroxysmal Supraventricular Tachycardia, Atrial Fibrillation. Anti-HTN: Has well-balanced effects between vascular and cardiac effects, in-between Nifedipine and Verapamil. |
| Dimenhydrinate
(Dramamine) |
Anti-Histamine (H1) | Sedating. Used in treatment of motion sickness. |
| Dinoprost
(PGF2alpha) |
Autocoid; PG Analog | Induces abortion. |
| Dinoprostone
(PGE2) |
Autocoid; PG Analog | Induces abortion. |
| Diphenhydramine
(Benadryl) |
Anti-Histamine (H1) | Sedating, due to CNS anti-histaminic effects. Can be beneficial to patient, to aid sleep or as anxiolytic. Sometimes used for its centrally-acting anti-cholinergic properties, as in an adjunct to anti-psychotic therapy. |
| Diphenoxylate | GI; Anti-diarrheal | Related to opiates; suppress diarrhea in a manner similar to meperidine. |
| Diphenoxylate | GI; Anti-Diarrheal | Opioid derivative that is specific to GI-tract, used to treat diarrhea. |
| Disopyramide | CV; Anti-Arrhythmic
Class-I (Na+-Blocker) |
Indicated for ventricular arrhythmias. Has prominent anti-cholinergic properties, and it may aggravate
heart failure. It does not effect digoxin levels.
Indications: PVC's, ventricular tachycardia |
| Disulfiram
(Antabuse) |
Abuse | Inhibits aldehyde dehydrogenase, causing build up of acetaldehyde and thus toxicities when taken with alcohol. Warn patients not to take cough syrup or other alcohol-containing consumer products. |
| Dobutamine | CV; Anti-CHF
beta-Agonist |
|
| Docusate Sodium
Docusate Potassium Docusate Magnesium |
GI; Laxative
Fecal softener |
Ca+2 is thought to be the superior product. Administered at bedtime, and it takes 1-2 days for the softened feces to pass through. They have no cathartic effect (don't add bulk or water). They only soften the feces and are used for constipation. |
| Doxacurium | Muscle-Relaxant; Competitive | |
| Doxazosin
(Cardura) |
CV; Anti-HTN
alpha1-Antagonist |
Similar to Prazosin but with longer half-life. |
| Doxepin | CNS; Anti-Depressant
1st Generation Tri-Cyclic |
Cardiotoxic. |
| Droperidol | CNS; Anti-Psychotic
Butyrophenone |
Also can be used as a fixed IV anesthetic. |
| Enalapril | CV; Anti-HTN, Anti-CHF
ACE-Inhibitor; pro-drug |
|
| Encainide | CV; Anti-Arrhythmic
Class-I (Na+-Blocker) Local Anesthetic |
Reduce conduction velocity and increase refractory period. Only should be used as last-ditch effort, high number of deaths found with this drug. |
| Enflurane | CNS; General Anesthetic
Inhalational Anesthetic |
Sensitizes the heart to catecholamines; hepatotoxic. |
| Epinephrine | Anti-Asthma
Bronchodilator; alpha,beta-agonist |
Substrate for COMT in the bronchioles, thus relatively short-acting.
Only given IV, used primarily in acute attacks; can be administered SQ in status asthmaticus. |
| Ergonovine | Autocoid; Ergot Alkaloid | Used to reduce post-partum hemorrhage, make uterus contract. |
| Ergotamine | Autocoid; Ergot Alkaloid | Acute treatment of migraine headaches. |
| Erythrityl Tetranitrate | CV; Anti-Anginal
Nitrates & Nitrites |
Longer-acting; oral or sublingual |
| Esmolol | CV; Anti-HTN
beta1-Blocker (cardioselective) Anti-Arrhythmic; Class II |
Only given IV because of its short-half life. |
| Ethacrynic Acid | Diuretic; Anti-CHF
Loop Diuretic; phenoxyacetic acid |
Slow-onset, partially irreversible inhibition of channels. |
| Ethosuximide | CNS; Anti-Convulsive
Petit-mal Succinimide |
Petit-mal treatment. First choice for petit mal.
MECH = Inhibit T-Type Ca+2 channels, normalizing firing. Is not highly bound to plasma proteins. Adverse Effects = sedation, Parkinsonian symptoms. May precipitate grand-mal, so give with primidone or phenytoin. |
| Ethyl Alcohol | Abuse | Metabolism: Alcohol ------> Aldehyde ------> Acetyl-CoA
Liver: Inhibits Cyt-P450 enzymes acutely, and increases (up-regulates) it chronically. Organ Effects: Vasodilation, hypothermia, GI irritation, diuresis |
| Famotidine
(Pepcid) |
GI; Peptic Ulcer
H2-Blocker |
Most potent, newest of H2-blockers. 20-50X more potent then cimetidine.
Adverse Effects: Muscle cramps, headache, constipation |
| Felodipine | CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker; Dihydropyridine |
Given parenterally. |
| Fentanyl | CNS; Opioid Analgesic
Fixed IV Anesthetic |
Only administered IV. Used as analgesic or fixed IV anesthetic. Highly lipophilic and accumulates in fat. |
| Fexofenadine
(Allegra) |
Anti-Histamine (H1)
Non-sedating |
The active metabolite of terfenadine. It is safer and does not have the same cardiotoxicity when administered with erythromycin and ketoconazole. |
| Flecainide | CV; Anti-Arrhythmic
Class-I (Na+-Blocker) Local Anesthetic |
Reduce conduction velocity and increase refractory period. Only should be used as last-ditch effort, high number of deaths found with this drug. |
| Flumazenil | CNS
Benzodiazepine Antagonist |
Competitive antagonist at benzodiazepine receptor, used to treat benzodiazepine overdose or toxicity. |
| Flunisolide | Anti-Asthma
Anti-Inflammatory; Corticosteroid |
|
| Fluoxetine
(Prozac) |
CNS; Anti-Depressant
3rd Generation SSRI's |
Often first-line treatment now. SSRI's are recommended for elderly.
Long half-life -- discontinue use within 5 weeks of using any MAOI. |
| Fluphenazine | CNS; Anti-Psychotic
Phenothiazine; piperazine |
Potent; high extra-pyramidal effects. |
| Flurazepam
(Dalmane) |
CNS; Depressant
Benzodiazepine |
Longer acting. Can be tolerance-forming. |
| Fluvoxamine | CNS; Anti-Depressant
3rd Generation SSRI's |
Very low incidence of anxiety as a side-effect. |
| Formoterol | Anti-Asthma
Bronchodilator; beta2-agonist |
Newer drug; longer action of 10-12 hrs. |
| Fosinopril | CV; Anti-HTN, Anti-CHF
ACE-Inhibitor; pro-drug |
|
| Furosemide
(Lasix) |
Diuretic; Anti-CHF
Loop Diuretic; sulfonamide |
Fast, reversible diuresis. Also has a carbonic anhydrase inhibitory effect. |
| GABApentin | CNS; Anti-Convulsive
Partial |
Partial seizure treatment, or as adjunct to grand-mal treatment.
MECH = Enhances depolarization-induced release of GABA. Effective in refractory patients, used in combination with phenytoin or carbamazepine. Well tolerated. |
| Gallamine | Muscle-Relaxant; Competitive | |
| Gemfibrozil | CV; Anti-Lipidemic
Fibric-acid derivative |
Lower plasma VLDL. Increase lipoprotein lipase activity ------> promote catabolism of VLDL.
Indications: wherever VLDL is elevated: Dysbetalipoproteinemia (III), Hypertriglyceridemia (IV), Chylomicronemia (V) |
| Glutethimide | CNS; Depressant
Piperidinedione |
Intermediate-acting. |
| Glycerine Suppositories | GI; Laxative
Miscellaneous |
Promote peristalsis by locally irritating mucous membranes of the rectum. |
| Glycerine | Diuretic
Osmotic Diuretic |
|
| Glycopyrrolate | CNS; General Anesthetic
Pre-Anesthetic Anti-Cholinergic; 4 compound |
Given as pre-anesthetic medication, to counteract bradycardia. It is not centrally acting so it doesn't counteract vomiting. |
| Guanabenz | CV; Anti-HTN; Sympatholytic
alpha2-agonist |
Direct alpha2-agonist ------> decrease sympathetic tone. |
| Guanadrel | CV; Anti-HTN; Sympatholytic
NE-Depleting agent |
Given PO. |
| Guanethidine | CV; Anti-HTN; Sympatholytic
NE-Depleting agent |
Given PO or IV. IV release may cause sudden release of endogenous norepinephrine.
Adverse Effects: orthostatic hypotension, fluid retention, diarrhea (due to reflex parasympatehtic overactivation), retrograde ejaculation. |
| Guanfacine | CV; Anti-HTN; Sympatholytic
alpha2-agonist |
Direct alpha2-agonist ------> decrease sympathetic tone. |
| Haloperidol
(Haldol) |
CNS; Anti-Psychotic
Butyrophenone |
Has the worst of all extra-pyramidal effects, and minimal anti-cholinergic effects. Very low hypotensive effects. |
| Halothane | CNS; General Anesthetic
Inhalational Anesthetic |
Sensitizes the heart to catecholamines; hepatotoxic. |
| Hydralazine | CV; Anti-HTN
Vasodilator Anti-CHF |
Indicated for CHF with renal dysfunction. It maintains renal blood flow despite vasodilation.
Given PO, for chronic anti-HTN treatment. Relaxes only arteriolar smooth muscle. May induce anginal attack or myocardial ischemia in patients with CAD, due to increased blood volume. Adverse effect: SLE-like syndrome. |
| Hydrochlorothiazide | Diuretic; Anti-HTN
Thiazide Diuretic |
Water-soluble. Most popular thiazide diuretic for treating HTN. Cheap. |
| Hydrocortisone | Anti-Asthma
Anti-Inflammatory; Corticosteroid |
Inhalant. Poorly absorbed, more restricted to local effects. |
| Hydroflumethiazide | Diuretic; Anti-HTN
Thiazide Diuretic |
|
| Hydromorphone | CNS; Opioid Analgesic | |
| Hydroxyzine | Anti-Histamine (H1)
Piperazine Anti-Emetic Anti-Anxiety |
A piperazine. Used in treatment of motion sickness, nausea, and as anti-anxiety.
Has several sub-cortical CNS effects, of which anti-emesis is the most prominent. |
| Hydroxyzine | GI; Anti-Emetic | Has several sub-cortical CNS effects, of which anti-emesis is the most prominent. Also anxiolytic, analgesic. |
| Imipramine
(Tofranil) |
CNS; Anti-Depressant
1st Generation Tri-Cyclic |
Sedating, which can be anxiolytic. Has prominent anti-cholinergic effects: urinary retention, blurred
vision, dry mouth. Cardiotoxic.
Desipramine is an active metabolite, which is more potent than imipramine itself. |
| Indapamide | Diuretic; Anti-HTN
Thiazide Diuretic |
Used to treat HTN. Both a thiazide diuretic and a direct vasodilator. |
| Innovar
(Droperidol + Fentanyl) |
CNS; General Anesthetic
Fixed IV Anesthetic |
Combination of (1) Droperidol (anti-psychotic) and (2) Fentanyl (opiate). It causes neuroleptanalgesia, a state of indifference, but not sleep. Useful in procedures where patient must cooperate. |
| Ipratropium Bromide | Anti-Asthma
Bronchodilator Anti-Muscarinic |
Inhalant. 4 anti-muscarinic does not cross BBB. Indicated for the treatment of exercise-induced asthma.
Not useful for other forms of asthma.
As an anti-muscarinic, it inhibits bronchoconstriction and reduces bronchial secretions. |
| Isocarboxazid | CNS; Anti-Depressant
1st Generation MAO-Inhibitor |
Hepatotoxicity, idiosyncratic, may occur. |
| Isoflurane | CNS; General Anesthetic
Inhalational Anesthetic |
Preferred General anesthetic in most cases. MAC = 1.40%. It has the least hepatotoxicity and does not appreciably decrease cardiac output. |
| Isoproterenol | Anti-Asthma
Bronchodilator; beta1,2-agonist |
Only given IV. Substrate for COMT in the bronchioles, thus relatively short-acting. Induces both bronchodilation and cardiac stimulation. |
| Isosorbide Dinitrite | CV; Anti-Anginal
Nitrates & Nitrites |
Solid; fast-acting. |
| Isradipine | CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker; Dihydropyridine |
|
| Kaolin & Pectin | GI; Anti-emetic; adsorbent | |
| Ketamine | CNS; General Anesthetic
Fixed IV Anesthetic |
Blocks glutamate receptors. Related to PCP and is hallucinogenic. Produces dissociative anesthesia.
No muscle relaxation, excellent amnesia. Breakthrough hallucinations = those which occur several weeks later. Most often used in kids. |
| Labetalol | CV; Anti-HTN
beta-Blocker (non-selective) alpha1-Blocker |
Causes hypotension, and is accompanied by less tachycardia than other alpha-antagonists, because it also
has beta-antagonizing activity.
Can be used to treat hypertensive emergencies. Adverse Effects: orthostatic hypotension, bronchospasm, hepatotoxicity |
| Lactulose Syrup | GI; Laxative
Miscellaneous |
It acidifies the colon, pulling NH3 into the bowel. Thus it is used to increase excretion of NH3 in patients with hepatic encephalopathy. |
| Levobunolol | CV; Anti-HTN
beta-Blocker (non-selective) |
|
| Levodopa (L-DOPA) | CNS; Movement Disorders
Anti-Parkinsonism |
Dopamine precursor, converted by a decarboxylase to active form in the CNS. Numerous central adverse effects with long-term use. |
| Levorphanol | CNS; Opioid Analgesic | |
| Lidocaine
(Local Anesthetic: brand-name Xylocaine) |
CV; Anti-Arrhythmic
Class-I (Na+-Blocker) Local Anesthetic; Amide |
Anti-Arrhythmic: Administered IV to avoid first-pass effect. Indications: Ventricular Arrhythmias. (1)
reentry dysrhythmias. Reduces action potential duration and shortens refractory period in purkinje fibers
------> improve slow conduction. (2) Suppress ectopic pacemakers. (3) Early onset arrhythmias post-MI.
Local Anesthetic: Xylocaine is close to ideal as a local anesthetic. Used for infiltration anesthesia, peripheral nerve block, epidural block. |
| Lisinopril | CV; Anti-HTN, Anti-CHF
ACE-Inhibitor; active drug |
Orally active drug. |
| Lithium | CNS
Anti-Bipolar Disorder |
Only works long-term -- two weeks latency period. Prescribe anti-psychotics for acute manic episodes, or
anti-depressants for acute depressive episodes.
Narrow therapeutic index. Toxicity ------> hypothyroidism (nodular goiter), leukocytosis, acne, tremor, Diabetes Insipidus, alterations in the ECG. |
| Loperamide | GI; Anti-Diarrheal | Opioid derivative that is specific to GI-tract, used to treat diarrhea. |
| Loperamide | GI; Anti-diarrheal | Related to opiates; suppress diarrhea in a manner similar to meperidine. |
| Loratadine
(Claritin) |
Anti-Histamine (H1)
Non-sedating |
Less sedating; does not cross BBB. |
| Lorazepam | CNS; Depressant
Benzodiazepine |
Short-acting; not metabolized by the P450 system. Used as Anti-Convulsant (Status Epilepticus) |
| Losartan | CV; Anti-HTN
Angiotensin AT1 Antagonist |
Non-peptide, orally administered pro-drug. Good for longer-term angiotensin-antagonist treatment. |
| Lovastatin
(Mevacor) |
CV; Anti-Lipidemic
HMG-CoA Reductase Inhibitor |
Reduce LDL and triglycerides, and increase HDL.
Indications: wherever LDL is elevated: Hypocholesterolemia (IIa), Combined Hyperlipoproteinemia (IIb). |
| Loxapine | CNS; Anti-Psychotic
Miscellaneous |
|
| LSD | Autocoid; Ergot Alkaloid | |
| Magnesium Citrate
Magnesium Sulfate Sodium Phosphate Sodium Tartrate |
GI; Laxative
Osmotic / Saline Agents |
Fast and powerful cathartics, act in 2-6 hrs. Indicated for (1) before diagnostic tests, (2) flushing entire GI tract of poisons or parasites. |
| Mannitol | Diuretic
Osmotic Diuretic |
Indications: (1) Prophylaxis of acute renal failure, (2) cerebral edema, and (3) used with furosemide to prevent cisplatin toxicity. |
| Maprotiline | CNS; Anti-Depressant
2nd Generation Miscellaneous Tetracyclic |
Almost no serotonergic effects. Particularly high incidence of seizures with this drug. |
| Meclizine | Anti-Histamine (H1) | Used in treatment of motion sickness. |
| Meperidine
(Demerol) |
CNS; Opioid Analgesic | Less potent, shorter-acting than morphine. Anti-cholinergic. Should be used with caution in presence of tachycardia, and should not be used for cancer pain. |
| Mepivacaine | Local Anesthetic; Amide | Used for infiltration anesthesia, peripheral nerve block, epidural block. |
| Meprobamate | CNS; Depressant
Carbamate |
Intermediate-acting. Muscle relaxant, anxiolytic, hypnotic, for the elderly. |
| Mesalamine | GI; Inflammatory bowel disease | Used in Ulcerative Colitis. Mechanism unknown; thought to locally inhibit cyclooxygenase in bowel mucosa. Adverse Effects = mild ones, except occasional hypersensitivity |
| Methadone | CNS; Opioid Analgesic | Long half-life, less efficacious drug. Used for maintenance therapy in heroin dependancy. Withdrawal is milder than morphine withdrawal. |
| Methaqualone | CNS; Depressant
Quinazolone |
Short-acting. |
| Methazolamide | Diuretic
Carbonic-Anhydrase Inhibitor |
Causes mild alkaline diuresis and metabolic acidosis. More lipid soluble, longer T1/2, less plasma-protein binding all favor entry into aqueous humor and CSF. Therefore used in prophylaxis of Glaucoma. |
| Methocarbamol | CNS; Depressant
Carbamate |
|
| Methoxyflurane | CNS; General Anesthetic
Inhalational Anesthetic |
Most potent (most lipophilic; highest Ostwald Coefficient) coefficient. MAC = 0.16%. Excellent muscle relaxant. Sensitizes the heart to catecholamines; hepatotoxic and nephrotoxic. |
| Methylcellulose | GI; Laxative
Bulk-forming agent |
|
| Methyldopa | CV; Anti-HTN; Sympatholytic
alpha2-agonist |
Pro-drug is converted to active form in NE neurons. alpha-methyl-NE is the active form, which then
indirectly decreases sympathetic tone by replacing NE in post-synaptic neurons.
Adverse Effects: hemolytic anemia, hepatotoxicity, increased prolactin secretion. |
| Methylergonovine | Autocoid; Ergot Alkaloid | Used to reduce post-partum hemorrhage, make uterus contract. |
| Methysergide | Autocoid; Ergot Alkaloid | Treatment of migraines. Blocks action of serotonin on cerebral blood vessels.
Side-effect = retroperitoneal fibrosis. |
| Metoclopramide | GI; Anti-emetic; central
Pro-kinetic |
MECH: Blocks dopamine in brain (anti-emetic) and in GI tract (pro-kinetic).
Indications: (1) Diabetic gastroparesis, (2) nausea and vomiting with cancer chemotherapy, (3) anorexia nervosa. |
| Metocurine | Muscle-Relaxant; Competitive | |
| Metoprolol | CV; Anti-HTN
beta1-Blocker (cardioselective) |
Local anesthetic membrane-stabilizing activity. Cardioselective: safer for use with asthmatics.
Indicated for treatment of essential tremor. |
| Mexiletine | CV; Anti-Arrhythmic
Class-I (Na+-Blocker) |
Similar to Lidocaine except administered orally. Used in treatment of ventricular arrhythmias. |
| Mg(OH)3 | GI; Peptic Ulcer
Antacid |
Most potent of antacids. Local antacid; not absorbed. Has diarrhea as a side-effect. Give it with
Aluminum (as in Mylanta) to minimize side-effect.
May cause CNS depression in patients with renal insufficiency. |
| Midazolam | CNS; Depressant
Benzodiazepine |
Used as a fixed IV anesthetic or as pre-anesthetic medication. Brief action due to redistribution from brain. |
| Milrinone | CV; Anti-CHF
Bipyrine |
Phosphodiesterase inhibitor ------> higher cAMP and Ca+2 ------> increase inotropic state. |
| Mineral Oil | GI; Laxative
Lubricant laxative |
Action 6-8 hours after administration. Indications: (1) Tearing of hemorrhoids or fissures, (2) temporary
relief of constipation.
Adverse Effects: (1) bowel granulomas, (2) may cause aspiration pneumonia in infants, (3) leaks through the anal sphincter, (4) interferes with absorption of fat-soluble vitamins |
| Minoxidil | CV; Anti-HTN
Vasodilator |
Given PO, for chronic anti-HTN treatment. Relaxes only arteriolar smooth muscle.
May induce anginal attack or myocardial ischemia in patients with CAD, due to increased blood volume. Also used for hair growth (hypertrichosis); CV side-effects (hypotension) may be seen when applied topically. |
| Misoprostol
(PGE1) |
GI; Peptic Ulcer
Cytoprotective Agent Autocoid; PG Analog |
Analog of PGE1. Inhibits gastric acid secretion; stimulates mucus secretion and cAMP production.
Cytoprotection: increased mucous, increased HCO3-.
Particularly useful in NSAID-induced ulcers. |
| Mivacurium | Muscle-Relaxant; Competitive | |
| Molindone | CNS; Anti-Psychotic
Miscellaneous |
|
| Monoctanoin | GI; Gallstones | Used when pigment stones are refractory to treatment by chenodiol. Administered through a nasobiliary catheter; only effective when in direct contact with the stones. |
| Morphine | CNS; Opioid Analgesic | Used as pre-anesthetic medication. ADVERSE EFFECTS: Increases degranulation of histamine ------>
low blood pressure, impaired respiration.
Conjugated with a glucuronic acid. Readily crosses BBB. |
| Nadolol | CV; Anti-HTN
beta-Blocker (non-selective) |
Has particularly long half-life and duration of action. |
| NaHCO3
(Alka-Seltzer) |
GI; Peptic Ulcer
Antacid |
Systemic antacid. It is absorbed, increasing Na+ and HCO3- load. It may lead to systemic metabolic alkalosis, and can cause acid-rebound. It creates an alkaline urine, facilitating clearance of drugs that are weak acids. |
| Nalbuphine | CNS; Opioid Analgesic | |
| Naloxone | CNS; Opioid Antagonist | Given IM; duration of action 1-4 hours. Used to treat heroin overdose and toxicity. |
| Naltrexone | CNS; Opioid Antagonist | Given orally, t1/2 of about 10 hrs. |
| Nedocromil Sodium | Anti-Asthma
Anti-Inflammatory Block Histamine Degranulation |
Inhibits degranulation of Mast Cell granules. |
| Neomycin | CV; Anti-Lipidemic
Miscellaneous |
Lower plasma LDL. Inhibits intestinal absorption of cholesterol ------> lower LDL. Indicated for Hypercholesterolemia (IIa) |
| Niacin
(Vitamin B1) |
CV; Anti-Lipidemic
Miscellaneous |
Lower plasma VLDL. Inhibits VLDL secretion ------> lower plasma VLDL.
Indications are wherever VLDL is increased: Hypercholesterolemia (IIa), Combined Hyperlipoproteinemia (IIb), Dysbetalipoproteinemia (III), Hypertriglyceridemia (IV) |
| Nicardipine | CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker; Dihydropyridine |
|
| Nifedipine | CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker; Dihydropyridine |
Has the strongest (most specific) vasodilator effects. |
| Nimodipine | CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker; Dihydropyridine |
Given parenterally. It has a high affinity for cerebral blood vessels. |
| Nitroglycerine | CV; Anti-Anginal
Nitrates & Nitrites |
Volatile liquid, fast-acting, sublingual. Most common preparation, because (1) rapid onset (1-3 minutes), and (2) short duration (20-30 min). Also available in other forms, which are longer-acting. |
| Nitrous Oxide (NO) | CNS; General Anesthetic
Inhalational Anesthetic |
Only remaining gaseous anesthetic. Least potent (least lipophilic, lowest Ostwald Coefficient) anesthetic. MAC >> 100. NO is an incomplete anesthetic. Fast rate of induction. Used in local procedures or in procedures where patient response is required. |
| Nizatidine
(Axid) |
GI; Peptic Ulcer
H2-Blocker |
Adverse Effects: Minor. Greater than 90% urinary excretion, more than the other drugs. |
| Nortriptyline | CNS; Anti-Depressant
1st Generation Tri-Cyclic |
Preferred TCA for geriatric population, due to fewer anti-cholinergic effects. Minimal sedative and anti-cholinergic effects.
Least likely to produce orthostatic hypotension, so it is the recommended TCA for patients with CHF. |
| Noscapine | Anti-Tussive | |
| Olanzapine | CNS; Anti-Psychotic
Miscellaneous |
|
| Olsalazine sodium | GI; Inflammatory bowel disease | Used to maintain remission of Ulcerative Colitis.
Contraindicated in persons with salicylate hypersensitivity. |
| Omeprazole | GI; Peptic Ulcer
Gastric-Pump Inhibitor |
Mech: Irreversibly inhibits the H+-pump by forming a covalent bond with a Cys residue. It blocks H+
transport into secretory vesicles ------> prevent acid formation.
Maximally effective when taken before meals; it requires acid in order to function, thus higher doses are required in fasting people. Indicated for Zollinger-Ellison syndrome, GERD, and non-bleeding PUD. |
| Ouabain | CV; Anti-CHF
Cardiac Glycoside |
Given IV for CHF emergencies, but primarily used only experimentally. The last lipid soluble and fastest acting of the digitalis drugs. |
| Oxazepam | CNS; Depressant
Benzodiazepine |
Short acting; not metabolized by the P450 system. |
| Oxprenolol | CV; Anti-HTN
beta-Blocker (non-selective) |
Has partial beta-agonist activity. |
| Oxycodone | CNS; Opioid Analgesic | |
| Oxymorphone | CNS; Opioid Analgesic | |
| Pancuronium | Muscle-Relaxant; Competitive | |
| Paraldehyde | CNS; Depressant | Hypnotic; rapid onset and short duration of action. Irritates GI tract. Used with institutionalized patients. Used especially to treat delirium tremens. Can be administered as an enema. |
| Paroxetine
(Paxil) |
CNS; Anti-Depressant
3rd Generation SSRI's |
Metabolism impaired in elderly. SSRI's are recommended for elderly. |
| Penbutolol | CV; Anti-HTN
beta-Blocker (non-selective) |
Has partial beta-agonist activity. |
| Pentaerythritol Tetranitrate | CV; Anti-Anginal
Nitrates & Nitrites |
Longer-acting; oral |
| Pentazocine | CNS; Opioid Analgesic | Partial opioid agonist, thus it can precipitate withdrawal if given after morphine. |
| Pentobarbitol | CNS; Depressant
Barbiturate |
Intermediate half-life. |
| Pergolide | CNS; Movement Disorders
Anti-Parkinsonism Ergoline Dopamine D2 Agonist |
Adjunct therapy to L-DOPA treatment, in patients who don't respond well to L-DOPA by itself. |
| Perphenazine | CNS; Anti-Psychotic
Phenothiazine; piperazine |
More extra-pyramidal and anti-emetic effects. |
| Phenelzine | CNS; Anti-Depressant
1st Generation MAO-Inhibitor |
Hepatotoxicity, idiosyncratic, may occur. |
| Phenobarbitol | CNS; Anti-Convulsive
Grand-mal Barbiturate |
Long half-life. Indicated for treatment of Grand-Mal / Partial Seizures, or Also used for Status Epilepticus. |
| Phenolphthalein
(Ex-lax) |
GI; Laxative
Contact-stimulant |
|
| Phenoxybenzamine | alpha-Blocker (non-selective) | Not used for treatment of HTN. Used for diagnosis and treatment of pheochromocytoma. |
| Phentolamine | alpha-Blocker (non-selective) | Not used for treatment of HTN. Used for diagnosis and treatment of pheochromocytoma. |
| Phenytoin
(Dilantin) |
CNS; Anti-Convulsive
Grand-mal Hydantoin |
(1) Grand-mal / partial treatment. MECH = prolong inactivation of Na+ channels, increasing seizure
threshold.
(2) Anti-Arrhythmic: similar to lidocaine. Indicated especially for digitalis toxicity. |
| Pimozidine | CNS; Anti-Psychotic
Miscellaneous |
|
| Pindolol | CV; Anti-HTN
beta-Blocker (non-selective) |
Has good oral bioavailability. Has partial beta-agonist activity. |
| Pipecuronium | Muscle-Relaxant; Competitive | |
| Piperacetazine | CNS; Anti-Psychotic
Phenothiazine; piperazine |
More extra-pyramidal and anti-emetic effects. |
| Pirbuterol | Anti-Asthma
Bronchodilator; beta2-agonist |
|
| Plantago seed | GI; Laxative
Bulk-forming agent |
|
| Pravastatin
(Pravachol) |
CV; Anti-Lipidemic
HMG-CoA Reductase Inhibitor |
Reduce LDL and triglycerides, and increase HDL.
Indications: wherever LDL is elevated: Hypocholesterolemia (IIa), Combined Hyperlipoproteinemia (IIb). |
| Prazosin
(Minipress) |
CV; Anti-HTN
alpha1-Antagonist |
Has less of an effect on reflex tachycardia and renin release, because it does not block the inhibitory alpha2 receptors. It can be used to treat hypertension. |
| Prednisone | Anti-Asthma
Anti-Inflammatory; Corticosteroid |
Taken orally. |
| Primidone | CNS; Anti-Convulsive
Grand-mal Barbiturate |
Grand-mal / partial treatment. Second-line drug. Has phenobarbitol as an active metabolite. Give with phenytoin; never give with phenobarbitol. |
| Probucol | CV; Anti-Lipidemic
Miscellaneous |
Lower plasma HDL. Structurally related to estrogens. Has minimal effects on LDL. Single Indication = Homozygous Familial Hypercholesterolemia (IIa), as an adjunct therapy. |
| Procainamide | CV; Anti-Arrhythmic
Class-I (Na+-Blocker) |
Given PO, IM, or IV. Well absorbed orally. Indications: similar to quinidine.
Can be potentiated by Amiodarone, Cimetidine, Ranitidine, Trimethoprim. Adverse Effects = SLE-like syndrome, agranulocytosis, fever and rash |
| Procaine | Local Anesthetic; Ester | Close to ideal as a local anesthetic. Used only for infiltration anesthesia or as spinal block. |
| Procyclidine | CNS; Movement Disorders
Anti-Parkinsonism Anti-Cholinergic |
Centrally acting anti-cholinergic used as adjunct therapy in Parkinson's, to inhibit cholinergic interneurons. Can be used as adjunct therapy with anti-psychotics, to attenuate extra-pyramidal effects. |
| Promethazine | Anti-Histamine (H1)
Phenothiazine |
Used chiefly as a sedative. |
| Propafenone | CV; Anti-Arrhythmic
Class-I (Na+-Blocker) Local Anesthetic |
Similar to encainide. |
| Propanolol | CV; Anti-HTN; Anti-Anginal
beta-Blocker (non-selective) Anti-Arrhythmic; Class II |
Given PO; undergoes extensive first-pass metabolism. Lipophilic, readily crosses BBB, used to treat
migraines and other CNS disorders.
Anti-Arrythmic: Similar to quinidine, and suppresses ventricular tachyarrhythmias. Anti-Anginal: Very common long-range therapy, used with nitrates. It decreases O2-demand of the heart. |
| Propofol | CNS; General Anesthetic
Fixed IV Anesthetic |
Popular drug for fixed anesthetic; also used as pre-anesthetic. Brief action because of redistribution from
brain (highly lipophilic).
Similar to the barbiturates but there is more rapid recovery. Depresses blood pressure at anesthetic doses. |
| Propoxyphene | CNS; Opioid Analgesic
Anti-Tussive |
Used to treat mild pain. |
| Protriptyline | CNS; Anti-Depressant
1st Generation Tri-Cyclic |
Minimal sedation. |
| Pyrilamine | Anti-Histamine (H1) | Sedating. Has greater GI side-effects than Diphenhydramine. |
| Quinapril | CV; Anti-HTN, Anti-CHF
ACE-Inhibitor; pro-drug |
|
| Quinidine | CV; Anti-Arrhythmic
Class-I (Na+-Blocker) |
Usually given PO, but also IM, IV.
Indications: atrial fibrillation, premature systole. Increases ventricular volume with atrial fib. Can prevent ectopic foci. Enhances AV transmission via anticholinergic effects. |
| Ramipril | CV; Anti-HTN, Anti-CHF
ACE-Inhibitor; pro-drug |
|
| Ranitidine
(Zantac) |
GI; Peptic Ulcer
H2-Blocker |
Gets into breast milk.
Inhibits Phase-I oxidation (Cyt-P450) |
| Remoxipride | CNS; Anti-Psychotic
Miscellaneous |
|
| Reserpine | CV; Anti-HTN; Sympatholytic
NE-Depleting agent |
Given PO.
Adverse Effects: psychic depression, stuffy nose, dry mouth, GI disturbance |
| Risperidone | CNS; Anti-Psychotic
Miscellaneous |
High extrapyramidal effects. |
| Rocuronium | Muscle-Relaxant; Competitive | |
| Salmeterol | Anti-Asthma
Bronchodilator; beta2-agonist |
Newer drug; longer action of 10-12 hrs. |
| Saralasin | CV; Anti-HTN
Angiotensin AT1 Antagonist |
It is a peptide, only given IV. It has short duration of action, and it has partial agonistic effects. Can be used in emergency situations for fast, short-term relief. Very short T1/2 |
| Scopolamine | GI; Anti-emetic; central
Anti-muscarinic |
Skin-patch applied to hairless area behind ear; indicated for motion sickness.
Given as pre-anesthetic medication, to counteract vomiting and bradycardia. |
| Scopolamine | CNS; General Anesthetic
Pre-Anesthetic Anti-Cholinergic; 3 compound |
Given as pre-anesthetic medication, to counteract vomiting (prevent excessive secretions) and bradycardia. It is centrally acting. |
| Selegiline | CNS; Movement Disorders
Anti-Parkinsonism MAO-B Inhibitor |
(1) MAO-B Inhibitor ------> inhibit breakdown of Dopamine and prolong action of L-DOPA. Adjunct
therapy to L-DOPA. Selegiline decreases on-off effects.
(2) Anti-oxidant: probably also has anti-oxidant properties, which helps prevent / retard damage to nigrostriatal neurons. |
| Senna | GI; Laxative
Contact-stimulant |
From senna plant. They stimulate GI mucosa ------> increase motility and secretions. |
| Sertraline
(Zoloft) |
CNS; Anti-Depressant
3rd Generation SSRI's |
Metabolism not different between young and elderly. SSRI's are recommended for elderly. |
| Simvastatin | CV; Anti-Lipidemic
HMG-CoA Reductase Inhibitor |
Reduce LDL and triglycerides, and increase HDL.
Indications: wherever LDL is elevated: Hypocholesterolemia (IIa), Combined Hyperlipoproteinemia (IIb). |
| Sodium Nitroprusside | CV; Anti-HTN
Vasodilator Anti-CHF |
Indications: (1) hypertensive emergencies, (2) acutely decompensated CHF, when the blood pressure is
inadequate to perfuse brain and kidneys.
Dilates both arteries and veins. Given IV, it is the fastest acting of the nitrate preparations. |
| Sodium Nitrite | CV; Anti-Anginal
Nitrates & Nitrites |
Can cause methemoglobinemia in high doses. It is therefore administered IV for treatment of cyanide poisoning. |
| Sotalol | CV; Anti-Arrhythmic
Class-III (K+-Blocker) |
|
| Sotalol | CV; Anti-HTN
beta-Blocker (non-selective) |
|
| Spironolactone | Diuretic
K+-sparing Diuretic Aldosterone Antagonist |
24-48 hours required to achieve maximal natriuresis.
Indicated for primary or secondary hyperaldosteronism. Adverse Effects: Gynecomastia, hirsutism, post-menopausal bleeding |
| Succinylcholine | Muscle-Relaxant; Depolarizing | Used in electroconvulsive therapy, ETC. |
| Sucralfate | GI; Peptic Ulcer
Cytoprotective Agent |
Sucralfate = Sucrose + Sulfate. It forms a mucus barrier that absorbs pepsin; increase mucus secretion,
HCO3- secretion, and PGE2 synthesis. It is not absorbed ------> minimal adverse effects. Aluminum
accumulation in blood may occur in people with renal insufficiency. It is only effective at an acidic pH:
don't give with antacids or H2-blockers.
Indicated for stress-induced ulcers |
| Sufentanil | CNS; Opioid Analgesic
Fixed IV Anesthetic |
10X more potent tha Fentanyl; used as Fixed IV Anesthetic. |
| Sulfasalazine | GI; Inflammatory bowel disease | For mild to moderate Ulcerative Colitis. Active metabolite = 5-aminosalicylic acid.
Adverse Effects: Anorexia, headaches, rash, hemolytic anemia, impaired folate absorption, abnormalities of sperm. |
| Temazepam | CNS; Depressant
Benzodiazepine |
|
| Terazosin | CV; Anti-HTN
alpha1-Antagonist |
Similar to Prazosin but with longer half-life. |
| Terbutaline | Anti-Asthma
Bronchodilator; beta2-agonist |
Given inhaled or PO. Not a substrate for COMT, thus longer duration. |
| Terfenadine
(Seldane) |
Anti-Histamine (H1)
Non-sedating |
Less sedating; does not cross BBB.
Blood levels go up with Erythromycin and Ketoconazole (due to Cyt-P450) ------> fatal arrhythmias. |
| Tetracaine | Local Anesthetic; Ester | Close to ideal as a local anesthetic. |
| Theophylline | Anti-Asthma
Bronchodilator; methylxanthine |
Given PO. Indicated for nocturnal asthma. Relatively long half-life. Smoking increases its clearance. CHF, liver disease, renal failure, decrease its clearance. |
| Thiopental | CNS; Depressant
Barbiturate |
Ultra short half-life. Used as a fixed IV anesthetic or as pre-anesthetic medication. Not analgesic; in fact
it increases awareness of pain. Often used with NO for its analgesic properties. Profound decreased
respiration.
Very rapid onset and rapid termination, because it is highly lipophilic and redistributes quickly. |
| Thioridazine | CNS; Anti-Psychotic
Phenothiazine; piperidine |
Tend to have minimal extrapyramidal effects, because the drug also has intrinsic anti-cholinergic activity. |
| Thiothixene | CNS; Anti-Psychotic
Thioxanthenes |
Low hypotensive effects. Potent; moderate (evenly distributed) side-effect profile. |
| Timolol | CV; Anti-HTN
beta-Blocker (non-selective) |
Local anesthetic membrane-stabilizing activity. |
| Tocainide | CV; Anti-Arrhythmic
Class-I (Na+-Blocker) |
Similar to lidocaine except given orally. Shortens action potentials and refractory periods in purkinje
fibers and cardiac muscle.
Agranulocytosis, 0.2% |
| Torsemide | Diuretic; Anti-CHF; Anti-HTN
Loop Diuretic; sulfonamide |
Fast, reversible diuresis. Long-acting. Once daily dosage for HTN: good side-effect profile, no hypokalemia or dyslipidemia. |
| Tranylcypromine | CNS; Anti-Depressant
1st Generation MAO-Inhibitor |
|
| Trazodone | CNS; Anti-Depressant
2nd Generation Miscellaneous |
Useful for severe anxiety, insomnia. No longer used much for depression.
Highly sedating, which can be anxiolytic. Has primarily serotonin effects, with little anti-cholinergic effects. Can show orthostatic hypotension. Used in elderly. Side-Effect = ventricular ectopic activity |
| Triamcinolone | Anti-Asthma
Anti-Inflammatory; Corticosteroid |
Inhalant. Poorly absorbed, more restricted to local effects. |
| Triamterene | Diuretic
K+-sparing Diuretic |
It inhibits Na+/K+-ATPase in collecting ducts. Also has an active (hydroxylated) metabolite. Both are
excreted in kidney. T1/2 = 3-5 hrs
Adverse Effect: Hyperkalemia, Metabolic Acidosis, renal stones |
| Triazolam
(Halcion) |
CNS; Depressant
Benzodiazepine |
Short-acting; primarily used as hypnotic. Can be tolerance-forming. |
| Trifluoperazine | CNS; Anti-Psychotic
Phenothiazine; piperazine |
More extra-pyramidal and anti-emetic effects. |
| Trihexyphenidyl | CNS; Movement Disorders
Anti-Parkinsonism Anti-Cholinergic |
Most popular of anti-cholinergics. Centrally acting anti-cholinergic used as adjunct therapy in Parkinson's, to inhibit cholinergic interneurons. Can be used as adjunct therapy with anti-psychotics, to attenuate extra-pyramidal effects. |
| Trimethadione | CNS; Anti-Convulsive
Petit-mal Oxazolidinedione |
Petit-Mal treatment. Only used after ethosuximide and VPA have failed.
MECH = Inhibit T-Type Ca+2 channels, normalizing firing. Not very bound to plasma proteins; Adverse Effects = sedation, blurred vision. May precipitate grand-mal, so give with primidone or phenytoin. TOXICITY: Blood dyscrasias, nephritis. Pretty toxic. |
| Trimethaphan | CV; Anti-HTN; Sympatholytic
Ganglionic blocker |
Given IV, for (1) hypotensive crisis, or (2) to induce hypotension during neurosurgery. |
| Tubocurarine | Muscle-Relaxant; Competitive | Used in Multiple Sclerosis. Acidosis increases its potency; alkalosis decreases its potency. |
| Urapidil | CV; Anti-HTN
alpha1-Antagonist |
Has less of an effect on reflex tachycardia and renin release, because it does not block the inhibitory alpha2 receptors. It can be used to treat hypertension. |
| Urea | Diuretic
Osmotic Diuretic |
|
| Ursodiol | GI; Gallstones | Natural bile salt. Suppresses hepatic synthesis of cholesterol, and inhibits absorption of cholesterol. Months of therapy required. |
| Valproic Acid (VPA) | CNS; Anti-Convulsive
Petit-mal Carboxylic Acid |
Petit-mal treatment, or as adjunct to Grand-mal (although that isn't approved yet in U.S.)
3 MECH's (proposed) = (1) prolong inactivation of Na+ channels, increasing seizure threshold. (2) Inhibit T-Type Ca+2 channels. And (3) Inhibit GABA trans-aminase, increasing GABA levels. Adverse Effects = it increases the likelihood of adverse effects of the barbiturates. Fulminant Hepatitis in children is a major drawback. |
| Vasopressin | ADH Analog | Indicated for Diabetes Insipidus |
| Vecuronium | Muscle-Relaxant; Competitive | |
| Verapamil | CV; Anti-HTN, Anti-Anginal
Ca+2-Blocker Anti-Arrhythmic; Class-IV |
Papaverine compound. Has the strongest (most specific) cardiac effects.
Anti-Arrhythmic: Treatment of Paroxysmal Supraventricular Tachycardia, Atrial Fibrillation. Adverse Effects = hypotension, heart-block, constipation. Increases serum digoxin levels. |
| Vigabatrin | CNS; Anti-Convulsive
Partial |
Partial seizure treatment.
MECH = Inhibit GABA transaminase, increasing GABA levels. |
| Viscous Lidocaine | GI; Anti-emetic; adsorbent | |
| Zafirlukast | Anti-Asthma
Anti-Inflammatory Anti-Leukotriene |
Leukotriene antagonist; blocks Leukotriene receptors in bronchial smooth muscle. Experimental.
Especially effective against exercise-induced and aspirin-sensitive asthma.
Adverse Effects: Headache, nausea, increased risk for infection. |
| Zileuton | Anti-Asthma
Anti-Inflammatory Anti-Leukotriene |
5-Lipoxygenase inhibitor ------> inhibit leukotriene synthesis. Experimental. Especially effective
against exercise-induced and aspirin-sensitive asthma.
Adverse Effects: Elevates liver enzymes, possible hepatotoxicity. |